0.05Open0.05Pre Close0 Volume57 Open Interest2.00Strike Price0.00Turnover237.90%IV95.24%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1946Delta0.4667Gamma21.00Leverage Ratio-0.0040Theta0.0001Rho4.09Eff Leverage0.0007Vega
Coherus BioSciences Stock Discussion
Almost form rhe double bottom.
D chart shows double bottom. Time to load up.
Coherus BioSciences Inc - Apotex Agreed to Pay to Company an Upfront Payment of $6.25 Mln United States Dollars under license agreement
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction
No comment yet